Breaking News

U.S. watching upcoming changes to Canada's drug prices


The United States is retaining Canada on its "watch list" of countries where insurance policies and practices may just pose a risk to American intellectual property rights. In its annual document on overseas perils to American rights holders, the Office of the United States Trade Representative (USTR) raised concerns about Canada's plan to recalibrate the way it calculates the price of prescribed drugs.



No comments